4.6 Article

Antisense inhibition of RNA polymerase α subunit of Clostridioides difficile

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Microbiology

Probiotics: insights and new opportunities for Clostridioides difficile intervention

Rusha Pal et al.

Summary: This review discusses the potential of probiotics in preventing and treating Clostridioides difficile infection (CDI) and its recurrence, reevaluates the efficacy of probiotic supplementation as an intervention for CDI, explores lessons learned from probiotic modulation of the immune system, and delves into avenues such as genome-scale metabolic network reconstructions and genome sequencing to identify novel strains and understand their functionality. The current regulatory framework, challenges, and future directions are also discussed.

CRITICAL REVIEWS IN MICROBIOLOGY (2023)

News Item Biochemistry & Molecular Biology

First oral fecal microbiota transplant therapy approved

Thiago Carvalho

Summary: Nature Medicine reports on the latest translational and clinical research news, including FDA approval of Seres' orally administered pill SER-109 for the treatment of recurrent Clostridioides difficile infection.

NATURE MEDICINE (2023)

Review Pharmacology & Pharmacy

Targeting Clostridioides difficile: New uses for old drugs

Jianwei Chen et al.

Summary: This paper presents a refined focus on 16 FDA-approved drugs that could be further developed as potential anti-C. difficile drugs. Only ursodeoxycholic acid has entered Phase IV clinical trials so far. Drug repurposing promotes the study of mechanistic and therapeutic strategies, providing new options for the development of next-generation anti-C. difficile agents.

DRUG DISCOVERY TODAY (2022)

Article Multidisciplinary Sciences

Basis of narrow-spectrum activity of fidaxomicin on Clostridioides difficile

Xinyun Cao et al.

Summary: Fidaxomicin is effective in treating Cdiff infections with minimal impact on gut commensals, and its activity is determined by a specific binding determinant in Cdiff RNA polymerase.

NATURE (2022)

Article Multidisciplinary Sciences

Discovery of a novel natural product inhibitor of Clostridioides difficile with potent activity in vitro and in vivo

Rusha Pal et al.

Summary: This study reports a novel natural product scaffold as a potential therapeutic choice for C. difficile infection. Six compounds with potent activity against C. difficile were identified and found to be non-toxic to human cells. These compounds also inhibited the production of key toxins and exhibited superior bactericidal activity compared to standard treatment. In a mouse model, one compound showed 100% protection against clinical manifestations of the disease.

PLOS ONE (2022)

Article Infectious Diseases

European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults

Joffrey van Prehn et al.

Summary: The document provides guidance on the treatment of Clostridioides difficile infection with a focus on the best treatment methods and factors influencing treatment strategies.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Article Multidisciplinary Sciences

High-throughput screening identifies a novel natural product-inspired scaffold capable of inhibiting Clostridioides difficile in vitro

Rusha Pal et al.

Summary: Clostridioides difficile is a pathogen causing diarrhea, taking advantage of microbial dysbiosis induced by antibiotics for infection. New lead molecules with potent anticlostridial activity have been discovered, suggesting potential for addressing recurrent C. difficile-mediated disease.

SCIENTIFIC REPORTS (2021)

Article Microbiology

Repurposing the Antiamoebic Drug Diiodohydroxyquinoline for Treatment of Clostridioides difficile Infections

Nader S. Abutaleb et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)

Article Infectious Diseases

Repurposing the Veterinary Antiprotozoal Drug Ronidazole for the Treatment of Clostridioides difficile Infection

Ahmed AbdelKhalek et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)

Article Infectious Diseases

Antibacterial and antivirulence activities of auranofin against Clostridium difficile

Ahmed AbdelKhalek et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)

Editorial Material Microbiology

The future of faecal transplants

Edward M. Giles et al.

NATURE REVIEWS MICROBIOLOGY (2019)

Article Medicine, General & Internal

Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant

Zachariah DeFilipp et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Medicine, Research & Experimental

A Novel Peptide Nucleic Acid against the Cytidine Monophosphate Kinase of S. aureus Inhibits Staphylococcal Infection In Vivo

Hyung Tae Lee et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2019)

Review Microbiology

Clostridium difficile colitis: pathogenesis and host defence

Michael C. Abt et al.

NATURE REVIEWS MICROBIOLOGY (2016)

Article Medicine, Research & Experimental

Targeting Multidrug-resistant Staphylococci with an anti-rpoA Peptide Nucleic Acid Conjugated to the HIV-1 TAT Cell Penetrating Peptide

Mostafa F. N. Abushahba et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2016)

Article Medicine, General & Internal

Clostridium difficile infection

Wiep Klaas Smits et al.

NATURE REVIEWS DISEASE PRIMERS (2016)

Article Infectious Diseases

Peptide nucleic acids inhibit growth of Brucella suis in pure culture and in infected murine macrophages

Parthiban Rajasekaran et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)

Article Infectious Diseases

Fidaxomicin inhibits toxin production in Clostridium difficile

Farah Babakhani et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)

Review Genetics & Heredity

NON-CODING RNA Gene regulation by antisense transcription

Vicent Pelechano et al.

NATURE REVIEWS GENETICS (2013)

Article Biochemistry & Molecular Biology

Targeting Listeria Monocytogenes rpoA and rpoD Genes Using Peptide Nucleic Acids

Ruba A. Alajlouni et al.

NUCLEIC ACID THERAPEUTICS (2013)

Article Medicine, Research & Experimental

Inhibition of Growth and Gene Expression by PNA-peptide Conjugates in Streptococcus pyogenes

Nadja Patenge et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2013)

Article Microbiology

Targeting Essential Genes in Salmonella enterica Serovar Typhimurium with Antisense Peptide Nucleic Acid

Muhammad A. Soofi et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)

Article Immunology

Fidaxomicin Inhibits Spore Production in Clostridium difficile

Farah Babakhani et al.

CLINICAL INFECTIOUS DISEASES (2012)

Article Immunology

Fidaxomicin Is an Inhibitor of the Initiation of Bacterial RNA Synthesis

Irina Artsimovitch et al.

CLINICAL INFECTIOUS DISEASES (2012)

Review Gastroenterology & Hepatology

Fecal microbiota transplantation and emerging applications

Thomas J. Borody et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)

Article Multidisciplinary Sciences

The JNK Inhibitor XG-102 Protects against TNBS-Induced Colitis

Kirstin Reinecke et al.

PLOS ONE (2012)

Article Medicine, General & Internal

Fidaxomicin versus Vancomycin for Clostridium difficile Infection

Thomas J. Louie et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Biochemistry & Molecular Biology

Molecular Evolution of Multisubunit RNA Polymerases: Structural Analysis

William J. Lane et al.

JOURNAL OF MOLECULAR BIOLOGY (2010)

Article Multidisciplinary Sciences

The role of toxin A and toxin B in Clostridium difficile infection

Sarah A. Kuehne et al.

NATURE (2010)

Review Biotechnology & Applied Microbiology

Hitting bacteria at the heart of the central dogma: sequence-specific inhibition

Louise Caroe Vohlander Rasmussen et al.

MICROBIAL CELL FACTORIES (2007)

Review Cell Biology

Peptide nucleic acid (PNA) binding-mediated gene regulation

G Wang et al.

CELL RESEARCH (2004)

Article Biochemistry & Molecular Biology

The translation start codon region is sensitive to antisense PNA inhibition in Escherichia coli

R Dryselius et al.

OLIGONUCLEOTIDES (2003)

Article Biotechnology & Applied Microbiology

Bactericidal antisense effects of peptide-PNA conjugates

L Good et al.

NATURE BIOTECHNOLOGY (2001)